Skip to main content
Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.91
-0.06 (-1.09%)
Apr 29, 2026, 10:23 AM EDT - Market open

Ardelyx Revenue

In the year 2025, Ardelyx had annual revenue of $407.32M with 22.09% growth. Ardelyx had revenue of $125.22M in the quarter ending December 31, 2025, with 7.82% growth.

Revenue (ttm)
$407.32M
Revenue Growth
+22.09%
P/S Ratio
3.59
Revenue / Employee
$832,965
Employees
489
Market Cap
1.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025407.32M73.71M22.09%
Dec 31, 2024333.62M209.16M168.06%
Dec 31, 2023124.46M72.30M138.61%
Dec 31, 202252.16M42.06M416.57%
Dec 31, 202110.10M2.53M33.36%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Immunocore Holdings 400.02M
Iovance Biotherapeutics 263.50M
Monte Rosa Therapeutics 123.67M
Wave Life Sciences 71.80M
Viridian Therapeutics 70.85M
Agios Pharmaceuticals 54.03M
Precigen 9.68M
Maze Therapeutics 2.50M
Revenue Rankings

ARDX News

More News